Document is current
Any future updates will be listed below
-
Authors
Le Foll, Bernard https://orcid.org/0000-0002-6406-4973
Naassila, Mickael https://orcid.org/0000-0002-9788-0918
Jeanblanc, Jérôme https://orcid.org/0000-0003-0353-2777
Hendershot, Christian S.
Chavarria, Jesus https://orcid.org/0000-0001-5864-2899
Calmels, Thierry
Krief, Stéphane
Berrebi-Bertrand, Isabelle
Uguen, Marilyne
Perrin, David
Ligneau, Xavier
Boileau, Isabelle https://orcid.org/0000-0002-9901-1484
Rusjan, Pablo M. https://orcid.org/0000-0003-0075-2918
Di Ciano, Patricia
Sabioni, Pamela
Capet, Marc
Robert, Philippe
Finance, Olivier
Lecomte, Jeanne-Marie
Schwartz, Jean Charles
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R21AA026035)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R21AA026035)
- License Information
-
More Information
Article History
Received: 23 May 2025
Revised: 18 December 2025
Accepted: 15 January 2026
First Online: 29 January 2026
Competing interests
: This work was supported by Bioprojet. Two authors, Jeanne-Marie Lecomte and Jean-Charles Schwartz are shareholders of Bioprojet. Thierry Calmels, Stéphane Krief, Isabelle Berrebi-Bertrand, Marilyne Uguen, David Perrin, Xavier Ligneau, Marc Capet, Philippe Robert, and Olivier Finance are employees of Bioprojet. Dr. Bernard Le Foll has received travel support to attend an event by Bioprojet. He is supported by CAMH, Waypoint Centre for Mental Health Care, a clinician-scientist award from the department of Family and Community Medicine of the University of Toronto and a Chair in Addiction Psychiatry from the department of Psychiatry of University of Toronto.
